coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Grange And Lakes PCN, Westmorland and Furness (LAD) · Health Inequalities Profile

    PCN U59570 · NHS Lancashire and South Cumbria Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,095

    Registered population

    56.1% aged 18–64

    31.6%

    Aged 65+

    ICB 20.0% · England 17.9%

    0.6%

    Ethnic minority (non-White)

    0.3% Asian

    0.0%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    6,244

    Hypertension register

    +4.80% in 3 yrs · England +5.60%

    245

    SMI register

    11.1% of Westmorland and Furness (LAD)'s

    468

    COPD register

    Reviews +5.80% in 3 yrs

    Forecast to 2030

    6,947

    Hypertension patients, 2030

    +703 on today

    53.3%

    QRISK ≥20% on statins, 2030

    +0.63pp over 3 yrs

    7.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    52.0%
    QRISK lipid therapy trails England and ICB.

    Only 52.0% of QRISK >= 20% patients receive lipid-lowering therapy (England 63.6%, ICB 61.4%), and 63.4% with CKD (England 70.3%), which could reflect recall.

    -2.5 pp
    SMI physical checks and heart failure reviews fell.

    Over 2023 to 2025, SMI BP checks fell 2.5 pp (England +4.4 pp), BMI checks fell 1.0 pp, and heart failure reviews changed -3.2%.

    72.9%
    Hypertension and diabetes control exceed national benchmarks.

    Hypertension treatment to target reaches 72.9% (England 70.3%) with 93.9% having a recent BP reading, while frail diabetes HbA1c control reaches 86.3% (England 81.9%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over represent 31.6% of the registered list against England's 17.9%

    Patients aged 65+ make up 31.6% (9,840) of the 31,095 registered patients, above Westmorland and Furness (25.9%), NHS Lancashire and South Cumbria ICB (20.0%) and England (17.9%). Those aged 0–17 comprise 12.3% (3,819) and 18–64 represent 56.1% (17,436). Associated Census resident data records 99.4% White and a 0.6% ethnic minority share. Summed practice lists total 32,095 versus the PCN base of 31,095. This older age profile is consistent with higher demand for frailty care.

    Age profile

    0–1712.3%
    18–6456.1%
    65+31.6%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White99.4%
    Asian0.3%
    Mixed0.1%
    Black0.1%
    Other0.1%

    Older people · falls rows are Westmorland and Furness (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Westmorland and Furness LA)1,5912,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.3%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)61.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Westmorland and Furness LA)7361,0219552024/25
    Falls deaths, all ages, per 100,000 (Westmorland and Furness LA)10.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN Core20 prevalence is 0.0% alongside an average IMD decile of 6.8

    The PCN records 0.0% Core20 prevalence (0 estimated patients), below Westmorland and Furness (9.2%), NHS Lancashire and South Cumbria ICB (30.6%), and England (21.0%), with an average IMD decile of 6.8 (Westmorland and Furness 6.0, ICB 5.0, England 5.5). All seven member practices record 0.0% Core20. With no resident Core20 LSOAs captured, health inequality targeting may focus on clinical vulnerability across the PCN's 245 severe mental illness patients (11.1% of the borough register) and 107 learning disability patients (8.2%).

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Ambleside0.0% · 0 patients
    Windermere0.0% · 0 patients
    Nutwood Medical0.0% · 0 patients
    St. Mary's0.0% · 0 patients
    Wraysdale House0.0% · 0 patients
    Cartmel0.0% · 0 patients
    Haverthwaite0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    245

    SMI register

    0.76% recorded prevalence

    107

    Learning disability register

    0.33% recorded prevalence

    10

    Care homes, 239 beds

    In the PCN catchment

    The PCN records 107 learning disability patients (0.3% vs Westmorland and Furness 0.6%, NHS Lancashire and South Cumbria ICB 0.6%, England 0.6%) and 245 severe mental illness patients (0.8% vs Westmorland and Furness 0.9%, ICB 1.2%, England 1.0%), alongside 10 catchment care homes (239 beds). In Westmorland and Furness, rough sleeping was 14 in the 2025 autumn snapshot.

    Severe mental illness: physical health checks

    Across 245 severe mental illness patients, BP checks reached 82.3% (England 83.4%) but fell 2.5 pp over three years (England +4.4 pp). BMI checks reached 81.4% but fell 1.0 pp (England +5.1 pp), which could reflect unverified recall gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,244

    Hypertension register

    +4.80%

    Register growth, 3 yrs

    Westmorland and Furness (LAD) +6.93% · England +5.60%

    +2.75pp

    BP control, under 80

    ≤140/90 · +3.83pp aged 80+

    +703

    More patients by 2030

    Forecast 6,947 (21.38%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 19.5% (6,244 patients), exceeding Westmorland and Furness (18.2%), the ICB (17.2%) and England (15.2%), consistent with an older population age structure. Practice prevalence ranges from 13.8% at Wraysdale House Surgery to 24.0% at Cartmel Surgery. Clinical control shows 93.9% have a recent blood pressure reading (England 90.0%) and 72.9% achieve treatment targets (England 70.3%), including 68.2% aged under 80 and 83.4% aged 80+. Three-year register growth of +4.8% trailed England (+5.6%). Strong blood pressure control places PCN management above England, but slower three-year register growth suggests opportunistic case-finding in lower-prevalence practices could be reviewed.

    Lipids and statins

    Lipid-lowering therapy lags England across high-risk groups: QRISK ≥ 20% coverage is 52.0% (England 63.6%), CKD is 63.4% (England 70.3%), and diabetes with CVD is 80.2% (England 84.4%). Fewer at-risk patients receive lipid-lowering therapy than national benchmarks, supporting a PCN review of high-risk prescribing recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202676,871£1.70£1.64£1.86£130,681
    Cardiovascular (all), 2025111,708£2.84£3.38£3.33£317,251

    For lipid-modifying drugs in 2026, the PCN prescribed 76,871 items at £1.70 per item (England £1.86, ICB £1.64). The PCN spent £12,299 less than at England's unit cost, but £4,612 more than at ICB unit cost. Spend per item sits below England but above ICB levels, alongside lower therapy coverage in high-risk cohorts.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +1.79%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.19%

    Asthma prevalence, PCN 3-yr % change

    The asthma register stands at 2,387 patients (7.7% vs England 6.6%). Annual reviews reached 68.3%, trailing Westmorland and Furness LAD (70.4%) while exceeding England (65.7%), leaving about 760 patients without a recorded review; reviews grew +1.8% over three years (England +4.4%). Paediatric asthma prescribing reached 1,925 items per 1,000 aged 5–19 (England 1,488). COPD prevalence is 1.5% (468 patients), with annual reviews at 79.9% (England 76.4%). Higher prescribing alongside unreviewed patients supports prioritising annual asthma reviews.

    Cancer register and children's immunisation

    Cancer register prevalence is 6.0% across 1,937 patients, exceeding England (3.8%) and Westmorland and Furness LAD (5.3%). In childhood immunisations, 6-in-1 coverage reaches 97.6% by 24 months (England 92.2%) but lags at 12 months at 89.4% (England 91.0%). At age 5, second-dose MMR (88.6%) and the 4-in-1 booster (84.1%) sit below the 95.0% target by 6.4 pp and 10.9 pp, which may reflect pre-school recall gaps.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.4%

    England 91.0%

    6-in-1 complete primary course at 24 months97.6%

    England 92.2%

    MMR dose 1 at 24 months97.6%

    England 88.3%

    MMR dose 2 at age 588.6%

    England 82.8%

    4-in-1 pre-school booster at age 584.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of staged cancers (4,642 of 8,863 with known stage) were diagnosed at stage 1 or 2, trailing England (55.3%) and 22.6 pp below the 75.0% national ambition by 2028 (about 2,010 extra cases needed), with the early-stage share falling 1.2 pp since 2013. Known stage was recorded for 74.6% of cases (8,863 of 11,883). Wider-system figures do not reflect PCN performance. Cancer prevalence is 6.0% (1,937 patients). Cervical screening coverage (aged 25–49) is 69.8% (England 66.8%, LAD 72.2%), dropping to 64.2% at Ambleside Health Centre and 56.8% at Windermere Health Centre.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For July 2026 (provisional), University Hospitals of Morecambe Bay NHS Foundation Trust met the 28-day faster diagnosis standard at 78.4% (standard 75.0%), in line with NHS Lancashire and South Cumbria Integrated Care Board (78.4%) and ahead of North Cumbria Integrated Care NHS Foundation Trust (78.3%) and Blackpool Teaching Hospitals NHS Foundation Trust (71.4%), against England's 79.3%. On the 62-day treatment standard, Morecambe Bay reached 72.4% (standard 85.0%), exceeding Blackpool Teaching Hospitals (67.5%), North Cumbria (70.9%) and England (71.2%), but below the ICB (73.6%). These waits describe provider performance rather than PCN referrals.

    Pathways within standard (%)of Morecambe BayNorth Cumbria Integrated CareBlackpoolLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)78.3978.3371.3878.3979.32
    31-day treatment (96%)95.2293.0997.9693.6292.50
    62-day referral to treatment (85%)72.3570.9067.4873.6271.16
    Diagnostic waits over 6 weeks (%)of Morecambe BayNorth Cumbria Integrated CareBlackpoolEngland
    MRI4.049.5921.8021.40
    CT13.760.6316.499.92
    Echocardiography10.551.337.5728.48
    Colonoscopy0.605.5013.0830.83
    Gastroscopy1.4510.9012.4729.02
    All 15 DM01 tests10.4416.6026.5423.14
    Community services activityWestmorland and Furness residentsLancashire and South Cumbria ICB
    Care contacts53,485193,720
    Referrals6,47029,855
    Patients with a contact13,44565,335

    Community services (residents of Westmorland and Furness), Jun 2026 (provisional). In the Community Services Dataset for June 2026 (provisional), adults aged 65 and over accounted for 67.9% of all community contacts among borough residents (36,330 of 53,485 contacts). While reported for borough residents rather than registered PCN patients, this older-age share is consistent with the PCN demographic profile (31.6% aged 65+).

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Windermere1200.086.6%78.7%96.6%
    Cartmel Surgery1030.098.6%75.9%96.0%
    Wraysdale House900.093.8%67.8%95.2%
    Haverthwaite1250.095.2%74.2%95.2%
    Nutwood Medical1150.086.5%72.4%93.7%
    Ambleside1160.084.9%83.1%90.6%
    St. Mary's Surgery1060.089.1%82.5%90.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWestmorland and Furness (LAD)AssetPCNWestmorland and Furness (LAD)
    Care homes (catchment)10 (239 beds)n/aSchools (catchment)40n/a
    Children's centres112Places of worship56316
    Libraries414Food banks (VCS)n/a2
    Day centres (VCS)n/a2Children and young people (VCS)n/a3
    Carers support groups (VCS)n/a2Primary schools (LA maintained)1582
    Primary academies327Special schools14

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured annual asthma review recall

    Annual asthma reviews reached 68.3% across 2,387 patients, below Westmorland and Furness LAD (70.4%) and leaving about 760 patients unreviewed; three-year growth was +1.8% (England +4.4%). For discussion: run a structured annual review and inhaler check recall across the asthma register, offering flexible appointment slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    SMI physical health check outreach

    Across 245 SMI patients, blood pressure checks (82.3% vs England 83.4%) fell 2.5 pp over three years (England +4.4 pp) and BMI checks (81.4% vs England 82.1%) fell 1.0 pp (England +5.1 pp). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Pharmacist-led lipid therapy recall

    Lipid-lowering therapy for QRISK ≥ 20% is 52.0%, below LAD (59.6%), ICB (61.4%) and England (63.6%) by 11.5 pp, with three-year growth of +1.2% (England +6.2%). Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Frailty and list reconciliation review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Clinical vulnerability outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check audit (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · SMI physical health check outreach (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Option 3 · Pharmacist-led lipid therapy recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs)NHS Long Term Plan (diabetes) and National Diabetes AuditPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15